British Journal of Cancer, ISSN 0007-0920, 07/2010, Volume 103, Issue 3, pp. 324 - 331
BACKGROUND: This multi-centre phase II clinical trial is the first prospective evaluation of radioembolisation of patients with colorectal liver metastases...
chemorefractory | metastases | radioembolisation | colorectal cancer | selective internal radiation therapy | SIRT | OPEN-LABEL | OXALIPLATIN | RANDOMIZED CONTROLLED-TRIAL | FLUOROURACIL | CANCER | FAILURE | HEPATIC ARTERIAL INFUSION | ONCOLOGY | CETUXIMAB PLUS IRINOTECAN | RADIOEMBOLIZATION | EPIDEMIOLOGY | Yttrium Radioisotopes - adverse effects | Prospective Studies | Humans | Middle Aged | Hepatic Artery | Liver Neoplasms - drug therapy | Male | Tomography, X-Ray Computed | Combined Modality Therapy | Liver Neoplasms - mortality | Liver Neoplasms - diagnostic imaging | Yttrium Radioisotopes - administration & dosage | Liver Neoplasms - radiotherapy | Survival Analysis | Aged, 80 and over | Quality of Life | Adult | Female | Aged | Leukocyte Count | Colorectal Neoplasms - pathology | Liver Neoplasms - secondary | Yttrium Radioisotopes - therapeutic use | Embolization, Therapeutic - methods | Clinical Study
chemorefractory | metastases | radioembolisation | colorectal cancer | selective internal radiation therapy | SIRT | OPEN-LABEL | OXALIPLATIN | RANDOMIZED CONTROLLED-TRIAL | FLUOROURACIL | CANCER | FAILURE | HEPATIC ARTERIAL INFUSION | ONCOLOGY | CETUXIMAB PLUS IRINOTECAN | RADIOEMBOLIZATION | EPIDEMIOLOGY | Yttrium Radioisotopes - adverse effects | Prospective Studies | Humans | Middle Aged | Hepatic Artery | Liver Neoplasms - drug therapy | Male | Tomography, X-Ray Computed | Combined Modality Therapy | Liver Neoplasms - mortality | Liver Neoplasms - diagnostic imaging | Yttrium Radioisotopes - administration & dosage | Liver Neoplasms - radiotherapy | Survival Analysis | Aged, 80 and over | Quality of Life | Adult | Female | Aged | Leukocyte Count | Colorectal Neoplasms - pathology | Liver Neoplasms - secondary | Yttrium Radioisotopes - therapeutic use | Embolization, Therapeutic - methods | Clinical Study
Journal Article
Surgical Endoscopy, ISSN 0930-2794, 1/2001, Volume 15, Issue 1, pp. 100 - 100
Postoperative abdominal pathogenic bands may produce intermittent subocclusive intestinal crises or chronic abdominal pain. Laparotomy has been widely used to...
Medicine & Public Health | Surgery | Gynecology | Hepatology | Gastroenterology | Abdominal Surgery | Proctology
Medicine & Public Health | Surgery | Gynecology | Hepatology | Gastroenterology | Abdominal Surgery | Proctology
Journal Article
In Vivo, ISSN 0258-851X, 11/2006, Volume 20, Issue 6A, pp. 711 - 714
Background: In patients locally progressing after two lines of chemotherapy, some locoregional approaches showed encouraging results in terms of local control...
Locoregional therapies | SIRT | Colorectal liver metastases | Radiotherapy Dosage | Yttrium Radioisotopes - adverse effects | Prospective Studies | Humans | Colorectal Neoplasms - radiotherapy | Treatment Outcome | Antineoplastic Agents - therapeutic use | Yttrium Radioisotopes - administration & dosage | Disease Progression | Microspheres | Time Factors | Liver Neoplasms - radiotherapy | Quality of Life | Colorectal Neoplasms - pathology | Liver Neoplasms - secondary | Infusions, Intra-Arterial
Locoregional therapies | SIRT | Colorectal liver metastases | Radiotherapy Dosage | Yttrium Radioisotopes - adverse effects | Prospective Studies | Humans | Colorectal Neoplasms - radiotherapy | Treatment Outcome | Antineoplastic Agents - therapeutic use | Yttrium Radioisotopes - administration & dosage | Disease Progression | Microspheres | Time Factors | Liver Neoplasms - radiotherapy | Quality of Life | Colorectal Neoplasms - pathology | Liver Neoplasms - secondary | Infusions, Intra-Arterial
Journal Article
Journal of Experimental and Clinical Cancer Research, ISSN 0392-9078, 12/2003, Volume 22, Issue 4, pp. 1 - 4
A great number of locoregional treatments are currently carried out to treat a variety of locoregional neoplastic diseases. Indications are the treatment of...
Neoplastic Locoregional Disease | SURGERY | INTRAPERITONEAL CHEMOTHERAPY | VASCULARIZATION | ONCOLOGY | PERITONEAL CARCINOMATOSIS | COLORECTAL-CANCER | EXPERIMENTAL LIVER METASTASES | neoplastic locoregional disease | BLOOD | Gastrointestinal Neoplasms - pathology | Neoplasm Metastasis - therapy | Neoplasm Metastasis - pathology | Humans | Liver Neoplasms - therapy | Gastrointestinal Neoplasms - therapy | Liver Neoplasms - secondary | Peritoneal Neoplasms - therapy | Peritoneal Neoplasms - secondary
Neoplastic Locoregional Disease | SURGERY | INTRAPERITONEAL CHEMOTHERAPY | VASCULARIZATION | ONCOLOGY | PERITONEAL CARCINOMATOSIS | COLORECTAL-CANCER | EXPERIMENTAL LIVER METASTASES | neoplastic locoregional disease | BLOOD | Gastrointestinal Neoplasms - pathology | Neoplasm Metastasis - therapy | Neoplasm Metastasis - pathology | Humans | Liver Neoplasms - therapy | Gastrointestinal Neoplasms - therapy | Liver Neoplasms - secondary | Peritoneal Neoplasms - therapy | Peritoneal Neoplasms - secondary
Journal Article
Journal of Experimental and Clinical Cancer Research, ISSN 0392-9078, 12/2003, Volume 22, Issue 4, pp. 229 - 232
Locoregional chemotherapy in the 80's was considered an effective palliative treatment for unresectable hepatic metastases: it significantly unproved the...
Experimental hepatic metastases | Bolus | Continuous infusion | Epiadryamicin concentration | SURVIVAL | bolus | RESECTION | continuous infusion | COLORECTAL-CARCINOMA | ARTERY FLOXURIDINE INFUSION | CHEMOTHERAPY | epiadryamicin concentration | LIVER METASTASES | EPIRUBICIN | ONCOLOGY | experimental hepatic metastases | COMPLICATIONS | Anthracyclines - pharmacokinetics | Drug Administration Routes | Hepatic Artery | Rats | Portal Vein | Rats, Sprague-Dawley | Tissue Distribution | Animals | Anthracyclines - administration & dosage | Liver Neoplasms, Experimental - drug therapy | Infusions, Intravenous | Chemotherapy, Cancer, Regional Perfusion - methods | Infusions, Intra-Arterial
Experimental hepatic metastases | Bolus | Continuous infusion | Epiadryamicin concentration | SURVIVAL | bolus | RESECTION | continuous infusion | COLORECTAL-CARCINOMA | ARTERY FLOXURIDINE INFUSION | CHEMOTHERAPY | epiadryamicin concentration | LIVER METASTASES | EPIRUBICIN | ONCOLOGY | experimental hepatic metastases | COMPLICATIONS | Anthracyclines - pharmacokinetics | Drug Administration Routes | Hepatic Artery | Rats | Portal Vein | Rats, Sprague-Dawley | Tissue Distribution | Animals | Anthracyclines - administration & dosage | Liver Neoplasms, Experimental - drug therapy | Infusions, Intravenous | Chemotherapy, Cancer, Regional Perfusion - methods | Infusions, Intra-Arterial
Journal Article
Journal of Experimental and Clinical Cancer Research, ISSN 0392-9078, 12/2003, Volume 22, Issue 4, pp. 181 - 185
Locoregional chemotherapy in the 80's was considered an effective palliative treatment for unresectable hepatic metastases. With the advent of new drugs...
Experimental liver metastases | Epirubicin | HEPATOCELLULAR-CARCINOMA | VASCULARIZATION | CHEMOEMBOLIZATION | PHARMACOKINETICS | RAT | ONCOLOGY | experimental liver metastases | epirubicin | HEPATIC-ARTERY INFUSION | CANCER | TUMORS | CHEMOTHERAPY | Hepatic Artery | Rats | Male | Epirubicin - administration & dosage | Portal Vein | Rats, Sprague-Dawley | Antibiotics, Antineoplastic - administration & dosage | Tissue Distribution | Animals | Liver Neoplasms, Experimental - drug therapy | Epirubicin - metabolism | Epirubicin - pharmacokinetics | Infusions, Intravenous | Antibiotics, Antineoplastic - metabolism | Antibiotics, Antineoplastic - pharmacokinetics | Chemotherapy, Cancer, Regional Perfusion | Infusions, Intra-Arterial
Experimental liver metastases | Epirubicin | HEPATOCELLULAR-CARCINOMA | VASCULARIZATION | CHEMOEMBOLIZATION | PHARMACOKINETICS | RAT | ONCOLOGY | experimental liver metastases | epirubicin | HEPATIC-ARTERY INFUSION | CANCER | TUMORS | CHEMOTHERAPY | Hepatic Artery | Rats | Male | Epirubicin - administration & dosage | Portal Vein | Rats, Sprague-Dawley | Antibiotics, Antineoplastic - administration & dosage | Tissue Distribution | Animals | Liver Neoplasms, Experimental - drug therapy | Epirubicin - metabolism | Epirubicin - pharmacokinetics | Infusions, Intravenous | Antibiotics, Antineoplastic - metabolism | Antibiotics, Antineoplastic - pharmacokinetics | Chemotherapy, Cancer, Regional Perfusion | Infusions, Intra-Arterial
Journal Article
Journal of Experimental and Clinical Cancer Research, ISSN 0392-9078, 12/2003, Volume 22, Issue 4, pp. 81 - 87
Hyperthermic antiblastic perfusion /HAP) has been proven to be an effective neoadjuvant treatment in the treatment of advanced soft tissue limb sarcoma. As a...
TNFα | Limb soft tissue sarcoma | Doxorubicin | Hyperthermic perfusion | TUMOR-NECROSIS-FACTOR | TNF alpha | ONCOLOGY | EXTREMITIES | doxorubicin | limb soft tissue sarcoma | hyperthermic perfusion | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Soft Tissue Neoplasms - mortality | Humans | Middle Aged | Soft Tissue Neoplasms - drug therapy | Extremities - pathology | Male | Sarcoma - drug therapy | Antibiotics, Antineoplastic - administration & dosage | Dose-Response Relationship, Drug | Disease-Free Survival | Maximum Tolerated Dose | Adolescent | Hyperthermia, Induced | Sarcoma - mortality | Sex Factors | Tumor Necrosis Factor-alpha - administration & dosage | Adult | Female | Neoadjuvant Therapy | Aged | Chemotherapy, Cancer, Regional Perfusion | Doxorubicin - administration & dosage
TNFα | Limb soft tissue sarcoma | Doxorubicin | Hyperthermic perfusion | TUMOR-NECROSIS-FACTOR | TNF alpha | ONCOLOGY | EXTREMITIES | doxorubicin | limb soft tissue sarcoma | hyperthermic perfusion | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Soft Tissue Neoplasms - mortality | Humans | Middle Aged | Soft Tissue Neoplasms - drug therapy | Extremities - pathology | Male | Sarcoma - drug therapy | Antibiotics, Antineoplastic - administration & dosage | Dose-Response Relationship, Drug | Disease-Free Survival | Maximum Tolerated Dose | Adolescent | Hyperthermia, Induced | Sarcoma - mortality | Sex Factors | Tumor Necrosis Factor-alpha - administration & dosage | Adult | Female | Neoadjuvant Therapy | Aged | Chemotherapy, Cancer, Regional Perfusion | Doxorubicin - administration & dosage
Journal Article
European Surgical Research, ISSN 0014-312X, 02/1998, Volume 30, Issue 1, pp. 26 - 33
Performances of totally implantable infusion systems were analyzed in patients with colorectal liver metastases undergoing intra-arterial treatment. It...
Original Paper | Infusion pumps | Colorectal neoplasms | Implantable devices | Infusions, intra-arterial | Liver neoplasms | implantable devices | SYSTEM | SURGERY | REGIONAL CHEMOTHERAPY | FLOXURIDINE INFUSION | infusions, intra-arterial | SCINTIGRAPHY | liver neoplasms | METASTATIC COLORECTAL-CANCER | DEGRADABLE STARCH MICROSPHERES | LIVER METASTASES | colorectal neoplasms | infusion pumps | COMPLICATIONS | EXPERIENCE | PERFUSION | Infusion Pumps, Implantable | Humans | Middle Aged | Liver Neoplasms - drug therapy | Male | Antineoplastic Agents - administration & dosage | Colorectal Neoplasms - drug therapy | Adult | Female | Aged | Liver Neoplasms - secondary | Floxuridine - administration & dosage | Infusions, Intra-Arterial
Original Paper | Infusion pumps | Colorectal neoplasms | Implantable devices | Infusions, intra-arterial | Liver neoplasms | implantable devices | SYSTEM | SURGERY | REGIONAL CHEMOTHERAPY | FLOXURIDINE INFUSION | infusions, intra-arterial | SCINTIGRAPHY | liver neoplasms | METASTATIC COLORECTAL-CANCER | DEGRADABLE STARCH MICROSPHERES | LIVER METASTASES | colorectal neoplasms | infusion pumps | COMPLICATIONS | EXPERIENCE | PERFUSION | Infusion Pumps, Implantable | Humans | Middle Aged | Liver Neoplasms - drug therapy | Male | Antineoplastic Agents - administration & dosage | Colorectal Neoplasms - drug therapy | Adult | Female | Aged | Liver Neoplasms - secondary | Floxuridine - administration & dosage | Infusions, Intra-Arterial
Journal Article
Il Giornale di chirurgia, ISSN 0391-9005, 1997, Volume 18, Issue 3, pp. 127 - 130
Journal Article
10.
Full Text
The distribution of the cis-platinum in tissues is modulated by the administration route
Journal of Inorganic Biochemistry, ISSN 0162-0134, 1989, Volume 36, Issue 3, pp. 159 - 159
Journal Article
Journal of Experimental and Clinical Cancer Research, ISSN 0392-9078, 1982, Volume 2, Issue 1, pp. 169 - 174
Journal Article
Journal of Experimental and Clinical Cancer Research, ISSN 0392-9078, 1991, Volume 10, Issue 3, pp. 177 - 180
It is known that hepatic artery ligation (H.A.L.) dramatically decreases blood flow in liver tumors. Past experiments have shown that almost normal blood flow...
LIVER METASTASES | BLOOD FLOW | HEPATIC ARTERY LIGATION | ONCOLOGY
LIVER METASTASES | BLOOD FLOW | HEPATIC ARTERY LIGATION | ONCOLOGY
Journal Article
Journal of Experimental and Clinical Cancer Research, ISSN 0392-9078, 1989, Volume 8, Issue 2, pp. 113 - 122
Journal Article
Journal of Surgical Oncology, ISSN 0022-4790, 1991, Volume 48, Issue S2, pp. 63 - 68
Several phase III clinical trials demonstrated that hepatic arterial chemotherapy for unresectable colorectal liver metastases is able to provide significantly...
colorectal metastasis | liver chemotherapy | CDDP | 5‐FU combination | CDDP and 5-FU combination
colorectal metastasis | liver chemotherapy | CDDP | 5‐FU combination | CDDP and 5-FU combination
Journal Article
Journal of Experimental and Clinical Cancer Research, ISSN 0392-9078, 1989, Volume 8, Issue 3, pp. 137 - 142
Journal Article
Journal of Experimental and Clinical Cancer Research, ISSN 0392-9078, 1991, Volume 10, Issue 4, pp. 253 - 258
Systemic or topic use of Hyaluronidase (HY.) has been suggested to improve antiblastic therapy efficiency in solid tumors. Since it was hypothesised that HY...
HEPATIC METASTASES | BLOOD FLOW | HEPATIC ARTERY LIGATION | ONCOLOGY
HEPATIC METASTASES | BLOOD FLOW | HEPATIC ARTERY LIGATION | ONCOLOGY
Journal Article
European Surgical Research, ISSN 0014-312X, 1985, Volume 17, Issue 1, pp. 38 - 43
Transmucosal gastric potential difference (TGPD) was measured in the antrum and fundus of the stomach in two groups of rats submitted to hemorrhagic shock. In...
Original Paper | Stomach | Gastric mucosal blood flow | Potential difference | Hemorrhagic shock | Rats | Male | Rats, Inbred Strains | Stomach Ulcer - physiopathology | Pyloric Antrum - physiopathology | Gastric Acid - secretion | Animals | Energy Metabolism | Membrane Potentials | Shock, Hemorrhagic - physiopathology | Gastric Mucosa - physiopathology | Gastric Fundus - physiopathology | Gastric Mucosa - blood supply
Original Paper | Stomach | Gastric mucosal blood flow | Potential difference | Hemorrhagic shock | Rats | Male | Rats, Inbred Strains | Stomach Ulcer - physiopathology | Pyloric Antrum - physiopathology | Gastric Acid - secretion | Animals | Energy Metabolism | Membrane Potentials | Shock, Hemorrhagic - physiopathology | Gastric Mucosa - physiopathology | Gastric Fundus - physiopathology | Gastric Mucosa - blood supply
Journal Article
Journal of Experimental and Clinical Cancer Research, ISSN 0392-9078, 1982, Volume 2, Issue 1, pp. 165 - 168
Journal Article
Journal of Experimental and Clinical Cancer Research, ISSN 0392-9078, 1982, Volume 1, Issue 1, pp. 83 - 88
Journal Article
Molecular biotherapy, ISSN 0952-8172, 1990, Volume 2, Issue 4, pp. 233 - 234
It has been ascertained that one of several possible reasons for negligible interferon activity in solid tumors, namely, hepatic metastases induced in rats...
Recombinant Proteins - metabolism | Interferon-alpha - metabolism | Animals | Humans | Interferon-alpha - blood | Liver Neoplasms - metabolism | Rats | Male | Liver Neoplasms - secondary | Rats, Inbred Strains
Recombinant Proteins - metabolism | Interferon-alpha - metabolism | Animals | Humans | Interferon-alpha - blood | Liver Neoplasms - metabolism | Rats | Male | Liver Neoplasms - secondary | Rats, Inbred Strains
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.